Their dual training gives them a unique perspective: Well - trained physician - scientists have the experience and instincts to
observe clinical syndromes, reflect on symptoms in the light of fundamental biological science, and pursue the study of those diseases through hypothesis - driven research.
The therapy was found to have an acceptable safety profile in all patients, with no
clinical or laboratory signs of systemic cytokine release
syndrome, a potentially serious toxicity that has been
observed in other CAR trials.